血液酒精浓度对胶质纤维酸性蛋白和泛素羧基末端水解酶L1诊断创伤性颅内出血准确性的影响:TRACK-TBI研究
本研究基于前瞻性TRACK-TBI研究,纳入18家美国一级创伤中心、TBI后24小时内就诊的2320例患者,评估急诊就诊时显著升高(>300 mg/dL)和中度升高(81-300 mg/dL)的血液酒精浓度对GFAP和UCH-L1预测CT阳性诊断准确性的影响。结果显示,显著升高和中度升高酒精浓度组CT阳性率分别为61.1%和60.5%,高于无升高组(46.9%)和无酒精浓度数据组(44.0%)。GFAP与UCH-L1联合预测CT阳性的AUC在显著升高组为0.949,高于中度升高组(0.858)、无升高组(0.849)和无数据组(0.883)。作者认为,中度及显著升高的血液酒精浓度不降低GFAP和UCH-L1对创伤性颅内损伤的诊断准确性,这些生物标志物可能有助于减少急性酒精中毒者不必要的脑CT检查。
要点
- 在TBI后24小时内就诊的2320例患者中,显著升高BAL组(>300 mg/dL)和中度升高BAL组(81-300 mg/dL)的CT阳性率分别为61.1%和60.5%,高于无升高BAL组(46.9%)和无BAL数据组(44.0%)。
- GFAP与UCH-L1联合预测CT阳性的AUC在显著升高BAL组为0.949,高于中度升高BAL组(0.858)、无升高BAL组(0.849)和无BAL数据组(0.883)。
- 显著升高和中度升高BAL组的血浆GFAP和UCH-L1水平高于无升高BAL组和无BAL数据组。
- 作者认为,中度及显著升高的BAL不降低GFAP和UCH-L1预测创伤性颅内损伤的诊断准确性,这些生物标志物可能有助于减少急性酒精中毒者不必要的脑CT。
适用人群与场景
- 美国18家一级创伤中心、TBI后24小时内就诊的患者,来自前瞻性TRACK-TBI研究。
- 按急诊就诊时BAL分组:显著升高(>300 mg/dL)54例(2.3%)、中度升高(81-300 mg/dL)332例(14.3%)、无升高(0-80 mg/dL)1209例(52.1%)、无BAL数据725例(31.3%)。
诊断标准与关键阈值
- BAL分层:显著升高>300 mg/dL;中度升高81-300 mg/dL;无升高0-80 mg/dL;无BAL数据。
- 血浆GFAP和UCH-L1采用Abbott i-STAT Alinity和ARCHITECT检测。
- 结局为脑CT阳性(创伤性颅内损伤)。
研究设计与关键结果
- 研究类型:前瞻性TRACK-TBI研究,纳入18家美国一级创伤中心、TBI后24小时内就诊的2320例患者。
- CT阳性率:显著升高BAL组61.1%、中度升高BAL组60.5%、无升高BAL组46.9%、无BAL数据组44.0%;全队列48.3%CT阳性。
- 血浆GFAP和UCH-L1水平:显著升高和中度升高BAL组高于无升高BAL组和无BAL数据组。
- GFAP与UCH-L1联合预测CT阳性的AUC:显著升高BAL组0.949,中度升高BAL组0.858,无升高BAL组0.849,无BAL数据组0.883。
证据类型、等级与局限
- 证据类型:前瞻性队列研究(TRACK-TBI研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,中度及显著升高的BAL不降低GFAP和UCH-L1预测创伤性颅内损伤的诊断准确性。
- 作者认为,这些生物标志物可能有助于减少急性酒精中毒者不必要的脑CT检查。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Acute intoxication is common in patients evaluated for traumatic brain injury (TBI). However, the effect of elevated blood alcohol levels (BALs) on the diagnostic accuracy of FDA-cleared biomarkers for evaluating traumatic intracranial injury on computed tomography (CT) scan, namely, glial fibrillary acidic protein (GFAP) and ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), has not been well studied.
METHODS: We investigated the effect of significantly elevated (>300 mg/dL) and modestly elevated BAL (81-300 mg/dL) at emergency department presentation on the diagnostic accuracy of GFAP and UCH-L1 for predicting a positive CT in patients presenting to 18 U.S. Level I trauma centers within 24 h of TBI as part of the prospective, Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) study. Plasma GFAP and UCH-L1 were measured using Abbott i-STAT Alinity and ARCHITECT assays. Discrimination was evaluated using the area under the receiver operating characteristic curve (AUC).
RESULTS: Of 2320 TRACK-TBI participants studied, 54 (2.3%), 332 (14.3%), 1209 (52.1%), and 725 (31.3%) had significantly elevated BAL, modestly elevated BAL, nonelevated BAL (0-80 mg/dL), and no BAL available, respectively; 48.3% of the cohort had a positive brain CT. Those with significantly elevated and modestly elevated BAL were more likely to have positive CT (61.1% and 60.5% vs. 46.9% and 44.0%) and had higher plasma GFAP and UCH-L1 levels than those with nonelevated BAL and no BAL available. The AUC of GFAP and UCH-L1 combined for predicting CT positivity was higher in those with significantly elevated BAL (0.949) than those with modestly elevated BAL (0.858), nonelevated BAL (0.849), and no BAL available (0.883).
CONCLUSIONS: Modestly and significantly elevated BAL does not lower the diagnostic accuracy of GFAP and UCH-L1 for predicting traumatic intracranial injury on CT. These biomarkers may be useful in decreasing avoidable brain CT imaging in persons with acute alcohol intoxication.
参考来源
- Harris M, Yue JK, Jain S, et al. Effect of blood alcohol on the diagnostic accuracy of glial fibrillary acidic protein and ubiquitin carboxy-terminal hydrolase L1 for traumatic intracranial hemorrhage: A TRACK-TBI study. Acad Emerg Med. 2025. PMID: 39967286. doi:10.1111/acem.15109
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。